<div class="container">

<table style="width: 100%;"><tr>
<td>warfarin</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Warfarin PK/PD data</h2>

<h3>Description</h3>

<p>Warfarin PK/PD data
</p>


<h3>Usage</h3>

<pre><code class="language-R">warfarin
</code></pre>


<h3>Format</h3>

<p>A data frame with 519 rows and 9 columns
</p>

<dl>
<dt>id</dt>
<dd>
<p>Patient identifier (n=32)</p>
</dd>
<dt>time</dt>
<dd>
<p>Time (h)</p>
</dd>
<dt>amt</dt>
<dd>
<p>Total drug administered (mg)</p>
</dd>
<dt>dv</dt>
<dd>
<p>Warfarin concentrations (mg/L) or PCA measurement</p>
</dd>
<dt>dvid</dt>
<dd>
<p>Dependent identifier Information (cp: Dose or PK, pca: PCA, factor)</p>
</dd>
<dt>evid</dt>
<dd>
<p>Event identifier</p>
</dd>
<dt>wt</dt>
<dd>
<p>Weight (kg)</p>
</dd>
<dt>age</dt>
<dd>
<p>Age (yr)</p>
</dd>
<dt>sex</dt>
<dd>
<p>Sex (male or female, factor)</p>
</dd>
</dl>
<h3>Source</h3>

<p>Funaki T, Holford N, Fujita S (2018). Population PKPD
analysis using nlmixr2 and NONMEM. PAGJA 2018
</p>


<h3>References</h3>

<p>O'Reilly RA, Aggeler PM, Leong LS. Studies of the coumarin
anticoagulant drugs: The pharmacodynamics of warfarin in man.
Journal of Clinical Investigation 1963; 42(10): 1542-1551
</p>
<p>O'Reilly RA, Aggeler PM. Studies on coumarin anticoagulant drugs
Initiation of warfarin therapy without a loading dose. Circulation
1968; 38: 169-177.
</p>


<h3>See Also</h3>

<p>Other nlmixr2 datasets: 
<code>Bolus_1CPTMM</code>,
<code>Bolus_1CPT</code>,
<code>Bolus_2CPTMM</code>,
<code>Bolus_2CPT</code>,
<code>Infusion_1CPTMM</code>,
<code>Infusion_1CPT</code>,
<code>Infusion_2CPTMM</code>,
<code>Infusion_2CPT</code>,
<code>Oral_1CPTMM</code>,
<code>Oral_1CPT</code>,
<code>Oral_2CPTMM</code>,
<code>Oral_2CPT</code>,
<code>Wang2007</code>,
<code>mavoglurant</code>,
<code>nimoData</code>,
<code>nmtest</code>,
<code>pheno_sd</code>,
<code>rats</code>,
<code>theo_md</code>,
<code>theo_sd</code>,
<code>wbcSim</code>
</p>


</div>